🇺🇸 PTGX — Protagonist Therapeutics, Inc.
Salud Compra fuertePrecio actual
140,24 USD
Máx. histórico
158,62
78 días
Caída desde máximo
-11,59%
Rango 52 semanas
75,44 – 160,81
Variación hoy
+0,62%
Cierre anterior
139,37
Rango de hoy
139,91 – 144,27
Volumen hoy
673.087
Peor caída histórica
-85,79%
01/09/2021 → 13/06/2022
Recuperado en 1001 días
Volatilidad anualizada ⓘ
89,34%
- Nombre completo
- Protagonist Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 141
- PER ⓘ
- 136,16 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 178,57 USD (puede no estar actualizado)
- Primera cotización
- 11/08/2016
- Precio actualizado
- hace 16 horas
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/01/2019 | 8,14 | 8,37 | 8,07 | 8,15 | +0,74% | 3,69% | 131.900 |
| 30/01/2019 | 8,10 | 8,16 | 7,88 | 8,09 | +0,25% | 3,46% | 149.700 |
| 29/01/2019 | 8,04 | 8,20 | 7,97 | 8,07 | -0,12% | 2,86% | 332.500 |
| 28/01/2019 | 7,93 | 8,19 | 7,88 | 8,08 | +1,00% | 3,91% | 201.200 |
| 25/01/2019 | 8,04 | 8,13 | 7,82 | 8,00 | +2,43% | 3,86% | 76.300 |
| 24/01/2019 | 8,01 | 8,20 | 7,71 | 7,81 | -3,34% | 6,12% | 57.300 |
| 23/01/2019 | 8,00 | 8,40 | 7,83 | 8,08 | +1,38% | 7,19% | 139.900 |
| 22/01/2019 | 8,04 | 8,26 | 7,95 | 7,97 | -2,21% | 3,86% | 126.400 |
| 18/01/2019 | 8,00 | 8,50 | 7,90 | 8,15 | +2,39% | 7,50% | 169.900 |
| 17/01/2019 | 7,26 | 8,27 | 7,26 | 7,96 | +9,34% | 13,91% | 275.500 |
| 16/01/2019 | 7,39 | 7,91 | 7,19 | 7,28 | -1,36% | 9,74% | 206.800 |
| 15/01/2019 | 7,15 | 7,51 | 6,94 | 7,38 | +3,94% | 7,97% | 247.500 |
| 14/01/2019 | 7,27 | 7,35 | 6,83 | 7,10 | -3,40% | 7,14% | 139.700 |
| 11/01/2019 | 7,15 | 7,41 | 7,05 | 7,35 | +1,80% | 5,03% | 248.800 |
| 10/01/2019 | 6,98 | 7,38 | 6,98 | 7,22 | +2,12% | 5,73% | 84.600 |
| 09/01/2019 | 7,08 | 7,35 | 7,00 | 7,07 | -0,70% | 4,94% | 113.200 |
| 08/01/2019 | 7,19 | 7,31 | 6,91 | 7,12 | -0,56% | 5,56% | 55.100 |
| 07/01/2019 | 6,79 | 7,60 | 6,79 | 7,16 | +3,17% | 11,93% | 78.800 |
| 04/01/2019 | 6,55 | 7,16 | 6,38 | 6,94 | +6,77% | 11,91% | 128.700 |
| 03/01/2019 | 6,82 | 7,00 | 6,45 | 6,50 | -5,66% | 8,06% | 71.900 |
| 02/01/2019 | 6,61 | 7,12 | 6,61 | 6,89 | +2,38% | 7,72% | 81.100 |
| 31/12/2018 | 6,42 | 6,93 | 6,42 | 6,73 | +5,82% | 7,94% | 96.000 |
| 28/12/2018 | 6,36 | 6,51 | 6,28 | 6,36 | +0,79% | 3,62% | 43.800 |
| 27/12/2018 | 6,32 | 6,59 | 6,23 | 6,31 | -0,94% | 5,70% | 37.600 |
| 26/12/2018 | 6,69 | 6,69 | 6,28 | 6,37 | -4,07% | 6,13% | 67.500 |
| 24/12/2018 | 6,57 | 6,81 | 6,57 | 6,64 | -0,45% | 3,65% | 37.900 |
| 21/12/2018 | 6,85 | 6,95 | 6,63 | 6,67 | -3,47% | 4,64% | 125.100 |
| 20/12/2018 | 6,55 | 6,92 | 6,45 | 6,91 | +3,75% | 7,25% | 88.700 |
| 19/12/2018 | 6,98 | 7,05 | 6,60 | 6,66 | -5,93% | 6,50% | 133.300 |
| 18/12/2018 | 6,79 | 7,12 | 6,63 | 7,08 | +3,51% | 7,22% | 93.800 |